These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27670221)

  • 1. Advances in the pathophysiology of primary immune thrombocytopenia.
    Perera M; Garrido T
    Hematology; 2017 Jan; 22(1):41-53. PubMed ID: 27670221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
    Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
    Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
    Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
    Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
    Bakchoul T; Sachs UJ
    Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
    Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
    Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in pathophysiology and treatment of immune thrombocytopenia].
    Kashiwagi H; Tomiyama Y
    Rinsho Ketsueki; 2015 Feb; 56(2):177-84. PubMed ID: 25765798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
    Marini I; Bakchoul T
    Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia.
    Zhou L; Xu F; Chang C; Tao Y; Song L; Li X
    Blood Coagul Fibrinolysis; 2016 Apr; 27(3):301-7. PubMed ID: 26484642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
    Fahim NM; Monir E
    Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura.
    Ma D; Zhu X; Zhao P; Zhao C; Li X; Zhu Y; Li L; Sun J; Peng J; Ji C; Hou M
    Ann Hematol; 2008 Nov; 87(11):899-904. PubMed ID: 18600325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
    Li J; Wang Z; Hu S; Zhao X; Cao L
    Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia.
    Nishimoto T; Kuwana M
    Semin Hematol; 2013 Jan; 50 Suppl 1():S43-9. PubMed ID: 23664516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Concepts in Immune Thrombocytopenia.
    Swinkels M; Rijkers M; Voorberg J; Vidarsson G; Leebeek FWG; Jansen AJG
    Front Immunol; 2018; 9():880. PubMed ID: 29760702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune thrombocytopenic purpura: pathophysiology and treatment].
    Godeau B
    Transfus Clin Biol; 2009 May; 16(2):101-5. PubMed ID: 19409827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytokines (IFN-gamma, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-beta1) levels in adults with immune thrombocytopenia.
    Ma L; Liang Y; Fang M; Guan Y; Si Y; Jiang F; Wang F
    Pharmazie; 2014 Sep; 69(9):694-7. PubMed ID: 25272942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment Progress of Immune Thrombocytopenia].
    Wu B; Wei Y; Zhang Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1212-5. PubMed ID: 26314476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.